Zhou, Y., et al., Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma. J Clin Lab Anal, 2022. 36(10): p. e24673.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siegel, R.L., et al., Colorectal cancer statistics, 2023. CA Cancer J Clin, 2023. 73(3): p. 233–254.

Article  PubMed  Google Scholar 

Chong, H.H., et al., Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma </= 5 cm. Eur Radiol, 2021. 31(7): p. 4824–4838.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imamura, T., et al., Surrogacy of recurrence-free survival for overall survival as an endpoint of clinical trials of perioperative adjuvant therapy in hepatobiliary-pancreatic cancers: a retrospective study and meta-analysis. Ann Surg, 2024. 279(6): p. 1025–1035.

Gao, Y., et al., Heterogeneity induced GZMA-F2R communication inefficient impairs antitumor immunotherapy of PD-1 mAb through JAK2/STAT1 signal suppression in hepatocellular carcinoma. Cell Death Dis, 2022. 13(3): p. 213.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao, W., H. Kim and M. Ho, Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells. PLoS One, 2015. 10(9): p. e0137664.

Article  PubMed  PubMed Central  Google Scholar 

Liu, X., et al., 32A9, a novel human antibody for designing an immunotoxin and CAR-T cells against glypican-3 in hepatocellular carcinoma. J Transl Med, 2020. 18(1): p. 295.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, X., et al., The expression of Ki-67 and Glypican– 3 in hepatocellular carcinoma was evaluated by comparing DWI and (18)F-FDG PET/CT. Front Oncol, 2023. 13: p. 1026245.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mauro, M., et al., Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients. Int J Mol Sci, 2023. 24(13).

Wen, R., et al., Performance of current versus modified CEUS LI-RADS in the diagnosis of non-hepatocellular carcinoma malignancies. Abdom Radiol (NY), 2023. 48(12): p. 3688–3695.

Article  PubMed  Google Scholar 

Wilson, S.R., Ultrasound: novel techniques. Abdom Radiol (NY), 2018. 43(4): p. 761.

Article  PubMed  Google Scholar 

Shin, J., et al., Contrast-enhanced ultrasound liver imaging reporting and data system for diagnosing hepatocellular carcinoma: A meta-analysis. Liver Int, 2020. 40(10): p. 2345–2352.

Article  PubMed  Google Scholar 

Li, N., et al., Predicting glypican-3 expression in hepatocellular carcinoma: A comprehensive analysis using combined contrast-enhanced ultrasound and clinical factors. Clin Hemorheol Microcirc, 2023. 85(4): p. 407–420.

Article  CAS  PubMed  Google Scholar 

Deng, Z., et al., Early detection of hepatocellular carcinoma via no end-repair enzymatic ethylation sequencing of cell-free DNA and pre-trained neural network. Genome Med, 2023. 15(1): p. 93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Capurro, M.I., et al., Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res, 2005. 65(14): p. 6245–54.

Article  CAS  PubMed  Google Scholar 

Gong, L., et al., Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinoma. PLoS One, 2014. 9(1): p. e87120.

Article  PubMed  PubMed Central  Google Scholar 

Montalbano, M., et al., Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma. Cell Oncol (Dordr), 2018. 41(2): p. 169–184.

Article  CAS  PubMed  Google Scholar 

Singh, A.K. and J.P. McGuirk, CAR T cells: continuation in a revolution of immunotherapy. Lancet Oncol, 2020. 21(3): p. e168-e178.

Article  PubMed  Google Scholar 

Li, D., et al., Bispecific GPC3/PD–1 CAR–T cells for the treatment of HCC. Int J Oncol, 2023. 62(4).

Geng, Z., et al., Radiomics Analysis of Susceptibility Weighted Imaging for Hepatocellular Carcinoma: Exploring the Correlation between Histopathology and Radiomics Features. Magn Reson Med Sci, 2021. 20(3): p. 253–263.

Article  CAS  PubMed  Google Scholar 

Meng, P., et al., Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells. Sci Rep, 2021. 11(1): p. 40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin, Y.J., et al., Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma. Dig Dis Sci, 2012. 57(11): p. 2917–23.

Article  CAS  PubMed  Google Scholar 

Li, L., et al., Poor Prognoses of Young Hepatocellular Carcinoma Patients with Microvascular Invasion: A Propensity Score Matching Cohort Study. Gastroenterol Res Pract, 2020. 2020: p. 4691425.

Guarino, M., et al., Pattern of macrovascular invasion in hepatocellular carcinoma. Eur J Clin Invest, 2021. 51(7): p. e13542.

Article  PubMed  Google Scholar 

Li, C., et al., Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy. J Clin Transl Hepatol, 2020. 8(3): p. 285–291.

Article  PubMed  PubMed Central  Google Scholar 

Zhang, Y., et al., Can IVIM help predict HCC recurrence after hepatectomy? Eur Radiol, 2019. 29(11): p. 5791–5803.

Article  PubMed  Google Scholar 

Pu, J.L., et al., Long-term oncological prognosis after curative-intent liver resection for hepatocellular carcinoma in the young versus the elderly: multicentre propensity score-matching study. BJS Open, 2022. 6(1).

Zhao, J., et al., Magnetic resonance imaging and diffusion-weighted imaging-based histogram analyses in predicting glypican 3-positive hepatocellular carcinoma. Eur J Radiol, 2021. 139: p. 109732.

Article  PubMed  Google Scholar 

Karaogullarindan, U., et al., Prognostic value and morphological findings of overexpression of glypican-3 in hepatocellular carcinoma. Eur J Gastroenterol Hepatol, 2023. 35(1): p. 89–93.

CAS  PubMed  Google Scholar 

Xu, L., et al., 20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3-mediated Wnt/beta–catenin signaling pathway. Acta Biochim Biophys Sin (Shanghai), 2024. 56(5): p. 688–696.

CAS  PubMed  Google Scholar 

Zeng, D., et al., Using new criteria to improve the differentiation between HCC and non-HCC malignancies: clinical practice and discussion in CEUS LI-RADS 2017. Radiol Med, 2022. 127(1): p. 1–10.

Article  PubMed  Google Scholar 

Esposto, G., et al., Dynamic contrast enhanced ultrasound in differential diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. World J Gastrointest Oncol, 2024. 16(6): p. 2804–2815.

Article  PubMed  PubMed Central  Google Scholar 

Liu, L.P., et al., Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression. World J Gastroenterol, 2021. 27(22): p. 3138–3141.

Article  PubMed  PubMed Central  Google Scholar 

Fei, X., et al., Value of high frame rate contrast-enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma. Insights Imaging, 2024. 15(1): p. 273.

Article  PubMed  PubMed Central  Google Scholar 

Cai, W.J., et al., Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Hepatocellular Carcinoma </=5 cm: Biological Characteristics and Patient Outcomes. Liver Cancer, 2023. 12(4): p. 356–371.

Article  CAS  PubMed  PubMed Central  Google Scholar